Posted On: 03/02/2016 3:04:36 PM
Post# of 72446
I just read the Yahoo article and the below clip speaks volumes. I think the Ovarian cancer phase II will be structured in this way and make it short and succinct.
"There is a "need to develop new clinical trial designs that are information-rich in terms of molecular characterization and metadata so that clinically useful conclusions can be drawn quickly from smaller study enrollments," said Jerome Strauss, chair of the committee that carried out the study."
"There is a "need to develop new clinical trial designs that are information-rich in terms of molecular characterization and metadata so that clinically useful conclusions can be drawn quickly from smaller study enrollments," said Jerome Strauss, chair of the committee that carried out the study."
(0)
(0)
***On 02/26/2016 at 8:33 am Scottsmith admited to posting under 5 aliases but his post was subsequently deleted. I have a screen shot and will email it to anyone interested.
